Addition of the LL-37 peptide at low concentrations (5 ng/ml) to lung cancer cell lines induced phosphorylation of the EGFR and activation of downstream MAP kinase signaling pathways, leading to enhanced proliferation and growth of anchorage-independent colonies. This evidence concerns the gene EGFR and lung carcinoma.